Merck Wins Appeal To Prohibit Generic Eye Drug
The Federal Circuit upheld a Merck & Co. Inc. patent Thursday which will keep a generic version of hypertension drug Trusopt off the market until the patent expires next year....To view the full article, register now.
Already a subscriber? Click here to view full article